Webinar: COVID-19 Webinar Updates for HIV Providers: Outpatient Opioid Use Disorder Treatment During COVID-19

Objectives

• Explain the national and state guidance including emergency regulatory changes for outpatient office-based buprenorphine treatment for Opioid Use Disorder given COVID
• Provide resources for staying up-to-date regarding outpatient care for persons with Opioid Use Disorder
• Review guidance on urine testing
• Provide example of changes in practice from University of Kentucky outpatient treatment for OUD

Presentation

Facilitated by 

• Michelle Lofwall, MD
  (University of Kentucky College of Medicine)
• Laura Fanucchi, MD MPH 
  (University of Kentucky College of Medicine)
  March 27, 2020

Objectives

• Explain the national and state guidance including emergency regulatory changes for outpatient office-based buprenorphine treatment for Opioid Use Disorder given COVID
• Provide resources for staying up-to-date regarding outpatient care for persons with Opioid Use Disorder
• Review guidance on urine testing
• Provide example of changes in practice from University of Kentucky outpatient treatment for OUD

Presentation

Facilitated by 

• Michelle Lofwall, MD
  (University of Kentucky College of Medicine)
• Laura Fanucchi, MD MPH 
  (University of Kentucky College of Medicine)
  March 27, 2020

Objectives

• Explain the national and state guidance including emergency regulatory changes for outpatient office-based buprenorphine treatment for Opioid Use Disorder given COVID
• Provide resources for staying up-to-date regarding outpatient care for persons with Opioid Use Disorder
• Review guidance on urine testing
• Provide example of changes in practice from University of Kentucky outpatient treatment for OUD

Presentation